If the relevant Director decides to suspend an
approved arrangement, or a part of an approved arrangement, under subsection
418(1), the Director must give the biosecurity industry participant
covered by the arrangement written notice stating that the arrangement, or the
part of the arrangement, is suspended for the period specified in the notice.